| HGNC Family | Non-coding RNAs |
| Name | microRNA 655 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐655 functions in a context‐dependent manner across diverse biological systems. In lung adenocarcinoma cells, miR‐655 is part of a cluster (with miR‐134 and miR‐487b) that becomes upregulated following TGF‑β1–induced epithelial–mesenchymal transition (EMT) and contributes to gefitinib resistance by targeting MAGI2 (reducing PTEN stability) (a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In contrast, function‐based screening in pancreatic cancer models revealed that enforced expression of miR‑655 restores epithelial markers (e.g. E‑cadherin) while suppressing EMT inducers and thereby limits cell migration and invasion (b."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In pituitary tumor cells, miR‑655, along with several 14q32–mapped microRNAs, targets the oncogene PTTG1 to inhibit proliferation, migration and invasion (c"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", and aberrant expression of miR‑655 has also been linked to hepatocellular carcinoma development (d."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn other cancer types, the role of miR‑655 appears even more dichotomous. In human breast cancer cells, COX‑2/EP4 signaling stimulates miR‑655 overexpression, which in turn promotes proliferation, migration, invasion, EMT and stem‐like properties via activation of NOTCH/WNT pathways and resistance to TGF‑β signaling (a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Similarly, increased miR‑655 (co‐operating with miR‑526b) enhances oxidative stress by upregulating TXNRD1 and suppressing its negative regulators, which further drives aggressive breast cancer phenotypes (b."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " In esophageal squamous cell carcinoma, low plasma levels of miR‑655 correlate with lymphatic invasion and metastasis, and restoration of miR‑655 levels inhibits proliferation, migration, invasion and EMT (c."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Moreover, in osteoarthritis, suppression of miR‑655 via CCN2‐mediated signaling leads to increased IL‑17 production and osteoclastogenesis (d."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": " Notably, preliminary studies also indicate roles for miR‑655 in ovarian cancer (e"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "and in the multifactorial etiology of cleft lip with or without cleft palate (f."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA recurrent regulatory theme emerging from several studies is the modulation of miR‑655 activity by long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs). For instance, in laryngeal squamous cell carcinoma, LINC01194 acts as a sponge for miR‑655, thereby promoting the expression of the oncogene SOX18 (a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Similarly, in endometrial carcinoma, lncRNA SNHG14 promotes malignancy through sequestration of miR‑655‑3p (b"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", while in hepatocellular carcinoma, both LINC01194 and circ_0001955 have been shown to sponge miR‑655‑3p, leading to derepression of SMAD5 and ACER3 respectively, and promoting tumor growth (c"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": "; d."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " In oral squamous cell carcinoma and T-cell acute lymphoblastic leukemia, similar ceRNA mechanisms have been reported where lncRNAs (or related transcripts) negatively regulate miR‑655‑3p, facilitating oncogenic signaling (e"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "; f."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": " Additionally, in liver-derived cells, treatment with Echinacea purpurea extract downregulates miR‑655‑3p, which in turn relieves repression of ABCG2, influencing drug transporter expression (g."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond cancer, miR‑655‑3p plays important roles in other physiological and pathological processes. In preeclampsia, miR‑655‑3p regulates trophoblast growth and invasiveness, potentially impacting placental development (a."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " In bone biology, overexpression of miR‑655‑3p under conditions simulating microgravity promotes osteogenic differentiation and reduces apoptosis via targeting LSD1 and activating the BMP‑2/Smad pathway, suggesting therapeutic potential in osteoporosis (b."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": " Finally, in papillary thyroid carcinoma, circ‑LDLRAD3 sponges miR‑655‑3p, leading to increased MAPK1 expression and tumor progression; restoration of miR‑655‑3p levels attenuates cell proliferation and invasion (c."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": " Additional investigations in osteosarcoma (d"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": "and studies exploring the impact of oxidative stress on miR‑655 expression (e"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "further underscore the versatile, context-specific functions of this microRNA.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-13-0448"}], "href": "https://doi.org/10.1158/1535-7163.MCT-13-0448"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24258346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24258346"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yosuke Harazono, Tomoki Muramatsu, Hironori Endo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0062757"}], "href": "https://doi.org/10.1371/journal.pone.0062757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23690952"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23690952"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hai-qian Liang, Ren-jie Wang, Cai-feng Diao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5003"}], "href": "https://doi.org/10.18632/oncotarget.5003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26320179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26320179"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Gang Wu, Kunming Zheng, Shuguan Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-016-0368-1"}], "href": "https://doi.org/10.1186/s13046-016-0368-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27259866"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27259866"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Mousumi Majumder, Leanna Dunn, Ling Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "COX-2 induces oncogenic micro RNA miR655 in human breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-18612-3"}], "href": "https://doi.org/10.1038/s41598-017-18612-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29321644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29321644"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Bonita Shin, Riley Feser, Braydon Nault, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR526b and miR655 Induce Oxidative Stress in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms20164039"}], "href": "https://doi.org/10.3390/ijms20164039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31430859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31430859"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jun Kiuchi, Shuhei Komatsu, Taisuke Imamura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-018-0929-3"}], "href": "https://doi.org/10.1186/s12943-018-0929-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30609933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30609933"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shan-Chi Liu, Hung-Lun Hsieh, Chun-Hao Tsai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CCN2 Facilitates IL-17 Production and Osteoclastogenesis in Human Osteoarthritis Synovial Fibroblasts by Inhibiting miR-655 Expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Bone Miner Res (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbmr.4661"}], "href": "https://doi.org/10.1002/jbmr.4661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35876037"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35876037"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "J-F Zha, D-X Chen "}, {"type": "b", "children": [{"type": "t", "text": "MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201905_17786"}], "href": "https://doi.org/10.26355/eurrev_201905_17786"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31114987"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31114987"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Mona Gajera, Neha Desai, Akiko Suzuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-655-3p and microRNA-497-5p inhibit cell proliferation in cultured human lip cells through the regulation of genes related to human cleft lip."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genomics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12920-019-0535-2"}], "href": "https://doi.org/10.1186/s12920-019-0535-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31122291"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31122291"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Da-Ming Liu, Hao Yang, Zhen-Nan Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2020.05.178"}], "href": "https://doi.org/10.1016/j.bbrc.2020.05.178"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32703403"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32703403"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "G-F Wang, L-N Wen "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202010_23391"}], "href": "https://doi.org/10.26355/eurrev_202010_23391"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33155197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33155197"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yang Liu, Jie Liu, Junkai Cui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2017678"}], "href": "https://doi.org/10.1080/21655979.2021.2017678"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34978464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34978464"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Kai Bai, Yubo Ma, Jian Li "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0001955 promotes hepatocellular carcinoma tumorigenesis by up-regulating alkaline ceramidase 3 expression through microRNA-655-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2023797"}], "href": "https://doi.org/10.1080/21655979.2021.2023797"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35034572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35034572"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sang Shin Lee, Jong Ho Choi, Seung Mook Lim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alteration of Pituitary Tumor Transforming Gene 1 by MicroRNA-186 and 655 Regulates Invasion Ability of Human Oral Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22031021"}], "href": "https://doi.org/10.3390/ijms22031021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33498448"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33498448"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jinhua Yang, Yingying Yang "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2044249"}], "href": "https://doi.org/10.1080/21655979.2022.2044249"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35220878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35220878"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Charles Awortwe, Meike Kaehler, Bernd Rosenkranz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Xenobiotica (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/00498254.2017.1390624"}], "href": "https://doi.org/10.1080/00498254.2017.1390624"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28990842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28990842"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "H Song, X Wang, J-C Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-655-3p inhibits growth and invasiveness of trophoblasts via targeting PBX3 and thus deteriorates preeclampsia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202010_23383"}], "href": "https://doi.org/10.26355/eurrev_202010_23383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33155190"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33155190"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "X-J Wang, J-W Liu, J Liu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-655-3p inhibits the progression of osteoporosis by targeting LSD1 and activating BMP-2/Smad signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Exp Toxicol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0960327120924080"}], "href": "https://doi.org/10.1177/0960327120924080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32431171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32431171"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Bingfei Zhang, Yiquan Peng, Lirong Zhou "}, {"type": "b", "children": [{"type": "t", "text": "Circ-LDLRAD3/miR-655-3p/MAPK1 axis enhances cell migration and invasion in papillary thyroid carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Biol (Noisy-le-grand) (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14715/cmb/2024.70.2.21"}], "href": "https://doi.org/10.14715/cmb/2024.70.2.21"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38430029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38430029"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "W Xing, W-Y Xu, L Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SP1-induced lncRNA LINC00689 overexpression contributes to osteosarcoma progression via the miR-655/SOX18 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202003_20486"}], "href": "https://doi.org/10.26355/eurrev_202003_20486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32196572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32196572"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Michael Stauber, Karsten Boldt, Christoph Wrede, et al. "}, {"type": "b", "children": [{"type": "t", "text": "1700012B09Rik, a FOXJ1 effector gene active in ciliated tissues of the mouse but not essential for motile ciliogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dev Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ydbio.2017.06.027"}], "href": "https://doi.org/10.1016/j.ydbio.2017.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28666954"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28666954"}]}]}]}
|
| Synonyms | HSA-MIR-655, MIRN655, MIR-655 |
| NCBI Gene ID | 724025 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR655 has 244 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for MIR655 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR655 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR655 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR655 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR655 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR655 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR655 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR655 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR655 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR655 from the GeneSigDB Published Gene Signatures dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR655 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR655 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR655 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR655 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |